134 related articles for article (PubMed ID: 33985696)
1. Differential effects of cisplatin combined with the flavonoid apigenin on HepG2, Hep3B, and Huh7 liver cancer cell lines.
Papachristou F; Anninou N; Koukoulis G; Paraskakis S; Sertaridou E; Tsalikidis C; Pitiakoudis M; Simopoulos C; Tsaroucha A
Mutat Res Genet Toxicol Environ Mutagen; 2021 Jun; 866():503352. PubMed ID: 33985696
[TBL] [Abstract][Full Text] [Related]
2. Kanglaite enhances the efficacy of cisplatin in suppression of hepatocellular carcinoma via inhibiting CKLF1 mediated NF-κB pathway and regulating transporter mediated drug efflux.
Chen C; Ai QD; Wei YH
J Ethnopharmacol; 2021 Jan; 264():113388. PubMed ID: 32918990
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
Okamura M; Hashimoto K; Shimada J; Sakagami H
Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
[TBL] [Abstract][Full Text] [Related]
5. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
[No Abstract] [Full Text] [Related]
6. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.
Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G
Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769
[TBL] [Abstract][Full Text] [Related]
7. Silence of p15 expression by RNAi enhances cisplatin resistance in hepatocellular carcinoma cells.
Fang D; Guo Y; Zhu Z; Chen W
Bosn J Basic Med Sci; 2012 Feb; 12(1):4-9. PubMed ID: 22364296
[TBL] [Abstract][Full Text] [Related]
8. The natural flavonoid apigenin sensitizes human CD44
Erdogan S; Turkekul K; Serttas R; Erdogan Z
Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
[TBL] [Abstract][Full Text] [Related]
9. Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns.
Cai J; Zhao XL; Liu AW; Nian H; Zhang SH
Phytomedicine; 2011 Mar; 18(5):366-73. PubMed ID: 20850954
[TBL] [Abstract][Full Text] [Related]
10. Apigenin, a flavonoid constituent derived from P. villosa, inhibits hepatocellular carcinoma cell growth by CyclinD1/CDK4 regulation via p38 MAPK-p21 signaling.
Li Y; Cheng X; Chen C; Huijuan W; Zhao H; Liu W; Xiang Z; Wang Q
Pathol Res Pract; 2020 Jan; 216(1):152701. PubMed ID: 31780054
[TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
Okamura M; Shimada J; Sakagami H
Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin and farnesol co-encapsulated PLGA nano-particles demonstrate enhanced anti-cancer potential against hepatocellular carcinoma cells in vitro.
Mondal J; Khuda-Bukhsh AR
Mol Biol Rep; 2020 May; 47(5):3615-3628. PubMed ID: 32314187
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
Miyata M; Morishita A; Sakamoto T; Katsura A; Kato K; Nishioka T; Toyota Y; Fujita K; Maeda E; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Fujiwara S; Nishiyama N; Iwama H; Himoto T; Hirashima M; Masaki T
Int J Oncol; 2015 Aug; 47(2):535-42. PubMed ID: 26060089
[TBL] [Abstract][Full Text] [Related]
16. 1β-OH-arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway.
Deng LJ; Lei YH; Quan JY; Li BJ; Zhang DM; Tian HY; Chen Y; Zhang EX; Chen L; Ye WC; Ning WM; Yu LZ; Liu JS
J Ethnopharmacol; 2021 Feb; 266():113443. PubMed ID: 33022344
[TBL] [Abstract][Full Text] [Related]
17. Purified vitexin compound 1 induces apoptosis through activation of FOXO3a in hepatocellular carcinoma.
Wang JG; Zheng XX; Zeng GY; Zhou YJ; Yuan H
Oncol Rep; 2014 Jan; 31(1):488-96. PubMed ID: 24247909
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Growth-Arrest-Specific Transcript 5 Improved Cisplatin Sensitivity in Hepatocellular Carcinoma Through Sponging miR-222.
Zhao P; Cui X; Zhao L; Liu L; Wang D
DNA Cell Biol; 2020 Apr; 39(4):724-732. PubMed ID: 32213078
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors.
Kogure T; Ueno Y; Iwasaki T; Shimosegawa T
Cancer Chemother Pharmacol; 2004 Apr; 53(4):296-304. PubMed ID: 14689231
[TBL] [Abstract][Full Text] [Related]
20. Selective Anti-Cancer Effects of Plasma-Activated Medium and Its High Efficacy with Cisplatin on Hepatocellular Carcinoma with Cancer Stem Cell Characteristics.
Li Y; Tang T; Lee HJ; Song K
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
